Your comprehensive partner for preclinical study

Your comprehensive partner for preclinical study

Provide competitive services worldwide with innovative technology, quality and cost-effectiveness

Accelerate NEW DRUG CLINICAL TRANSLATION

Accelerate NEW DRUG CLINICAL TRANSLATION

Focus on clinically relevant disease models and translational tools

Global Services

Global Services

AAALAC accredited facility Help NMPA & FDA IND filings of new drugs

Large animal disease models and medical device testing

Large animal disease models and medical device testing

Well-equipped surgical suites and experienced team of clinical experts

scroll down

Our Competitive Technology Platforms

See more →
Orthotopic Tumor Models

Orthotopic Tumor Models

Dominating the Field with the Largest Repository of Clinically Relevant Orthotopic Tumor Models

Immuno-Oncology 2.0

Immuno-Oncology 2.0

Diversified IO Animal Modeling Platform with Target-Specific, Immune Subpopulation–Selective Humanization

Autoimmune

Autoimmune

Humanized auto-immune disease models for evaluation of human specific new drugs

Cancer Supportive Care Evaluation

Cancer Supportive Care Evaluation

Our Company

See more →

ClinBridge is committed to offering a comprehensive suite of preclinical solutions for new drugs and medical devices testing, focusing on the development of innovative evaluation technologies, clinically relevant tumor pharmacology, tumor immunity and autoimmunity animal models. Leveraging our expertise in preclinical new drug evaluation, ClinBridge is capable of providing competitive preclinical services worldwide, emphasizing quality, swift turn-around time, and cost-effectiveness

Founded in
120 +

Customers Served

Company Staff
50 +

Studies For IND

Preclinical Study Platforms

Target Discovery
and Validation Molecule Biology Cell Function Immunoassays In Vitro Drug Screening Target Discovery and Validation
More More
In Vivo
Pharmacology Oncology Immuno-Oncology Inflammation and Autoimmune Cardiovascular Disease Metabolic Disease In Vivo Pharmacology
More More
ADME-DMPK In vitro ADME In vivo DMPK Bioanalysis Bioequivalence ADME-DMPK
More More
Non-GLP Toxicity MTD Test DRF Test Immunotoxicity Local toxicity Genotoxicity Non-GLP Toxicity
More More
Pathology Histopathology IHC/IF Tissue Microarray Clinical Pathology Pathology
More More

News

See more →

Latest information

Picture Name

Exhibition activities

Picture Name

Announcement for the Infectious Diseases, Vaccines, and Immunity Frontier Symposium: Dr. WenQing Yang, Our Co-Founder/CSO, to Attend WCID2024 and Deliver Keynote Address

Picture Name

Oct 23,2024

Dr. Wenqing Yang, CSO, Invited to Attend the Second International Congress on Clinical Immunology and Allergy (ICIA 2023)

Picture Name

From October 23-25, 2023, the second International Congress on Clinical Immunology and Allergy (ICIA) was grandly held in Boston, USA. Dr. Wenqing Yang, our company's CSO, attended the event as a member of the Scientific Committee on behalf of ClinBridge Bio.

Oct 27,2023

Dr. Yang Wenqing, CSO, Invited to Serve on the Scientific Committee for the 2023 International Conference on Oncology and Cancer Research and Delivers a Keynote Speech

Picture Name

Dr. Yang Wenqing, founder and CSO of ClinBridge Bio, was invited to organize and delivered a keynote speech at the International Conference on Cancer and Oncology Research held on June 19-20, 2023, in Rome, Italy.

Jun 22,2023

Dr. Wenqing Yang, CSO of Yunqiao Purui, Invited to Attend the Fifth Global Infectious Diseases Summit (WCID 2023)

Picture Name

The Fifth Global Infectious Diseases Conference (WCID) was held from October 23rd to 25th, 2023, in Boston, USA. Dr. WenQing Yang, co-founder and CSO of our company, attended this important event as a member of the Scientific Committee and delivered a keynote speech. The three-day conference featured nearly 100 academic presentations by experts and scholars from around the world, including prominent U.S. virology, infectious diseases, and public health experts such as Dr. Ranjan Ramasamy, Dr. Astagneau Pascal, Dr. Yongqing Li, and Professor Astagneau Pascal from France. As a member of the Scientific Committee, Dr. Yang also chaired the conference's scientific section.

Oct 27,2023